Healthcare Realty Trust (NYSE:HR) Updates FY25 Earnings Guidance

Healthcare Realty Trust (NYSE:HR) updated its FY25 earnings guidance on Wednesday. The company provided earnings per share guidance of $1.56 to $1.60 for the period, compared to the consensus earnings per share estimate of $1.59. Healthcare Realty Trust also updated its FY 2025 guidance to 1.560-1.600 EPS.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Jefferies Financial Group cut shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and lowered their price target for the stock from $19.00 to $17.00 in a research report on Thursday, January 2nd. Wedbush lowered shares of Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $18.00 to $16.00 in a research note on Thursday, January 2nd. Finally, JPMorgan Chase & Co. lowered shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective on the stock. in a research note on Friday, December 20th. Two investment analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $17.00.

Healthcare Realty Trust Stock Down 1.3 %

Healthcare Realty Trust stock traded down $0.22 during midday trading on Wednesday, hitting $16.77. 3,385,673 shares of the stock were exchanged, compared to its average volume of 2,369,625. Healthcare Realty Trust has a 52 week low of $12.77 and a 52 week high of $18.90. The company has a fifty day simple moving average of $16.69 and a two-hundred day simple moving average of $17.42. The stock has a market capitalization of $5.94 billion, a PE ratio of -10.61 and a beta of 0.94.

Healthcare Realty Trust (NYSE:HR) last announced its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. The firm had revenue of $309.77 million for the quarter, compared to analyst estimates of $303.81 million. During the same quarter in the previous year, the firm posted $0.39 earnings per share. The business’s revenue was down 6.3% on a year-over-year basis. As a group, equities research analysts anticipate that Healthcare Realty Trust will post 1.55 EPS for the current fiscal year.

Insider Buying and Selling at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director Peter F. Sr Lyle, Sr. acquired 10,000 shares of the stock in a transaction dated Friday, December 13th. The shares were bought at an average cost of $17.21 per share, for a total transaction of $172,100.00. Following the completion of the acquisition, the director now directly owns 26,576 shares of the company’s stock, valued at approximately $457,372.96. This trade represents a 60.33 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thomas N. Bohjalian acquired 7,750 shares of the stock in a transaction dated Friday, November 22nd. The stock was acquired at an average price of $17.39 per share, for a total transaction of $134,772.50. Following the completion of the acquisition, the director now directly owns 50,002 shares of the company’s stock, valued at $869,534.78. The trade was a 18.34 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 18,750 shares of company stock valued at $323,723. 0.56% of the stock is currently owned by corporate insiders.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.